Harmony Biosciences posts record sales for narcolepsy drug, maps synthetic CBD plans
The Pennsylvania-based drugmaker anticipates results from a Phase 3 trials of ZYN002 by the third quarter.
The post Harmony Biosciences posts record sales for narcolepsy drug, maps synthetic CBD plans appeared first on Green Market Report.
